Libratus

SYRS- Potential beginning of the bullish trend

NASDAQ:SYRS   Syros Pharmaceuticals, Inc.
Follow me and smash that like button! Bio-pharmaceutical company aims to treat cancer and genetic diseases. Not the investment. Please do your own due diligence.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.